NCI, CRUK award $100M in Cancer Grand Challenge grants

The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear”

Thomas J. Lynch Jr. and Howard A. “Skip” Burris III lead two institutions that couldn’t be more different—an NCI-designated Comprehensive Cancer Center on one side of the country and a for-profit research enterprise on the other—but they stay up at nights worrying about the same thing.

Kennedy’s claims notwithstanding, NCI clinical trials are delayed, enrollments reduced
NCI’s Steven A. Rosenberg: “Almost all patients are getting delayed by about a month, but then again, we’re turning away more patients.”

Natalie Phelps, a 43-year-old mother of two, has stage 4 colorectal cancer. She has become a central figure in the controversy over the dysfunction the Trump administration’s RIFs and budget cuts have brought to NIH.

An opportunity for Trump: Position U.S. cancer science to lead the world

Last November, the American public voted on America First causes, which include the greatest scientific discovery and achievement enterprise in the world: The National Institutes of Health. NIH has made America first in biomedical science for the past century.

Health tracking poll reveals most Americans opposed to cuts to federal health agencies

The Kaiser Family Foundation has released a tracking poll compiling data from the first 100 days of the Trump administration.

May 16, 2025

Vol.51 No.19

By Claire Marie Porter

Cancer Policy

Harvard amends lawsuit against Trump administration, includes additional defendants and funding cuts

Harvard University filed an amended lawsuit against the Trump administration, seeking to add two more federal agencies as defendants and to address the administration’s widening efforts to cut the university’s federal funding—now targeting over $2.6 billion and all future grants.

May 16, 2025

Vol.51 No.19

By Claire Marie Porter

In Brief

Texas Children’s and MD Anderson receive $150M gift from Kinder Foundation to launch Kinder Children’s Cancer Center

Texas Children’s Hospital and The University of Texas MD Anderson Cancer Center announced a $150 million gift from Kinder Foundation.

May 16, 2025

Vol.51 No.19

NCI, CRUK award $100M in Cancer Grand Challenge grants

YOU MAY BE INTERESTED IN

The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear”

Kennedy’s claims notwithstanding, NCI clinical trials are delayed, enrollments reduced
NCI’s Steven A. Rosenberg: “Almost all patients are getting delayed by about a month, but then again, we’re turning away more patients.”

An opportunity for Trump: Position U.S. cancer science to lead the world

Health tracking poll reveals most Americans opposed to cuts to federal health agencies

Harvard amends lawsuit against Trump administration, includes additional defendants and funding cuts

Texas Children’s and MD Anderson receive $150M gift from Kinder Foundation to launch Kinder Children’s Cancer Center

Renew today!

Subscriber content

Never miss an issue!

Login

NCI, CRUK award $100M in Cancer Grand Challenge grants

YOU MAY BE INTERESTED IN

The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient livesIn a time of uncertainty, “react to the knowns, not the fear”

Kennedy’s claims notwithstanding, NCI clinical trials are delayed, enrollments reducedNCI’s Steven A. Rosenberg: “Almost all patients are getting delayed by about a month, but then again, we’re turning away more patients.”

An opportunity for Trump: Position U.S. cancer science to lead the world

Health tracking poll reveals most Americans opposed to cuts to federal health agencies

Harvard amends lawsuit against Trump administration, includes additional defendants and funding cuts

Texas Children’s and MD Anderson receive $150M gift from Kinder Foundation to launch Kinder Children’s Cancer Center

Never miss an issue!

Login

The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear”

Kennedy’s claims notwithstanding, NCI clinical trials are delayed, enrollments reduced
NCI’s Steven A. Rosenberg: “Almost all patients are getting delayed by about a month, but then again, we’re turning away more patients.”